Eton Pharmaceuticals, Inc. financial data

Symbol
ETON on Nasdaq
Location
21925 W. Field Parkway, Suite 235, Deer Park, IL
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 183 % +5.89%
Quick Ratio 52.7 % +399%
Debt-to-equity 235 % +123%
Return On Equity -18.6 % +57.4%
Return On Assets -5.55 % +73.9%
Operating Margin -1.39 % +93.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.8M shares +3.8%
Common Stock, Shares, Outstanding 26.8M shares +4.16%
Entity Public Float 80.2M USD -5.31%
Common Stock, Value, Issued 27K USD +3.85%
Weighted Average Number of Shares Outstanding, Basic 26.9M shares +4.33%
Weighted Average Number of Shares Outstanding, Diluted 26.6K shares +3.23%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 58.2M USD +85.4%
Research and Development Expense 4.51M USD -14.7%
General and Administrative Expense 30.9M USD +57%
Operating Income (Loss) -807K USD +87.1%
Nonoperating Income (Expense) -1.21M USD -341%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.03M USD +36.9%
Income Tax Expense (Benefit) 101K USD -66.4%
Net Income (Loss) Attributable to Parent -4.13M USD +38.3%
Earnings Per Share, Basic 0 USD/shares +40.7%
Earnings Per Share, Diluted 0.02 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 25.4M USD +43.4%
Accounts Receivable, after Allowance for Credit Loss, Current 14.5M USD +197%
Inventory, Net 23.8M USD +1050%
Assets, Current 68.4M USD +169%
Property, Plant and Equipment, Net 18K USD -60%
Operating Lease, Right-of-Use Asset 324K USD +47.9%
Intangible Assets, Net (Excluding Goodwill) 32.9M USD +437%
Other Assets, Noncurrent 12K USD 0%
Assets 102M USD +220%
Accounts Payable, Current 12.1M USD +469%
Accrued Liabilities, Current 7.46M USD -34.7%
Liabilities, Current 38.6M USD +112%
Operating Lease, Liability, Noncurrent 492K USD +239%
Other Liabilities, Noncurrent 4.27M USD
Liabilities 77.7M USD +323%
Retained Earnings (Accumulated Deficit) -112M USD -3.83%
Stockholders' Equity Attributable to Parent 24M USD +78%
Liabilities and Equity 102M USD +220%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.09M USD
Net Cash Provided by (Used in) Financing Activities 394K USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 26.8M shares +4.16%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.48M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 642K USD +238%
Deferred Tax Assets, Valuation Allowance 20.6M USD -4.31%
Deferred Tax Assets, Gross 21M USD -3.19%
Operating Lease, Liability 515K USD +135%
Depreciation 48K USD +6.67%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 725K USD +194%
Property, Plant and Equipment, Gross 480K USD +5.96%
Operating Lease, Liability, Current 23K USD -68.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 127K USD +41.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 22K USD -75.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 210K USD +650%
Lessee, Operating Lease, Liability, to be Paid, Year Three 135K USD +487%
Deferred Tax Assets, Operating Loss Carryforwards 14.1M USD -8.43%
Unrecognized Tax Benefits 382K USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 139K USD
Operating Lease, Payments 23K USD +130%
Additional Paid in Capital 136M USD
Amortization of Intangible Assets 1.88M USD +126%
Deferred Tax Assets, Net of Valuation Allowance 404K USD +139%
Share-based Payment Arrangement, Expense 1.2M USD +46.2%
Interest Expense 1.16M USD +389%